Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
09-11 April, 2025
Not Confirmed
Not Confirmed
01-03 April, 2025
Peptide-Based Therapeu...Peptide-Based Therapeutics Summit
Not Confirmed
Not Confirmed
01-03 April, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
09-11 April, 2025
Industry Trade Show
Not Confirmed
01-03 April, 2025
Peptide-Based Therapeu...Peptide-Based Therapeutics Summit
Industry Trade Show
Not Confirmed
01-03 April, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/molecular-glue-degraders-lilly-abbvie-sign-billion-dollar-deals-bms-leads-with-three-late-stage-drugs
06 Feb 2020
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/foamix-announces-publication-of-phase-3-studies-evaluating-fmx103-for-the-treatment-of-papulopustular-rosacea-in-journal-of-the-american-academy-of-dermatology-301000340.html
16 Jan 2020
// BUSINESS WIRE
14 Jan 2020
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/foamix-announces-amzeeq-minocycline-achievement-of-preferred-status-on-express-scripts-national-preferred-formulary-one-of-the-largest-commercial-formularies-in-the-us-300986316.html
18 Nov 2019
// BIOSPACE
https://www.biospace.com/article/releases/foamix-announces-enrollment-completion-of-phase-2-acne-clinical-trial-for-fcd105-minocycline-3-percent-and-adapalene-0-3-percent-combination-foam/?s=95
12 Nov 2019
// Mark Terry BIOSPACE
https://www.biospace.com/article/foamix-and-menlo-therapeutics-merge-to-focus-on-dermatology/?s=79
ABOUT THIS PAGE